dm+d
24450004
Medicine Compliance Aid Stability
genericNon-proprietary
Non-proprietary
generic
Tablets 100mg, 400mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from light
Protect from moisture
Protect from light moisture and excessive heat in well closed containers
17 November 2022
Lactation Safety Information
Limited published evidence of safety
Doses up to 15mg/kg produce low levels in milk
Monitor infant for jaundice—mildly elevated liver enzymes reported in one infant (also receiving rifampicin)
18 September 2018